PsychoGenics Expands its In Vivo Capabilities with the Addition of Preclinical Magnetic Resonance Imaging Technology Services in Partnership with Ekam Imaging.

Předmět:	PARTNERSHIP agreements MAGNETIC resonance imaging IN vivo toxicity testing PHARMACEUTICAL research
Zdroj:	Biomedical Market Newsletter; 2/14/2012, Vol. 21, p1-3, 3p
Abstrakt:	The article provides information on establishment of an agreement between Psychogenics Inc. and Ekam Imaging Inc.. The agreement is done to provide magnetic resonance imaging technology services of Ekam Imaging Inc. in awake animals to complement in vivo capabilities and drug discovery services of Psychogenics Inc.. The article also offers brief information on Psychogenics Inc. and Ekam Imaging Inc..
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu